Biohit Oyj Class B (EUR)
BIOBV
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 2.20 | 2.29 |
| 52-Wk Range | | |
| Last Close | 2.28 |
| Mkt Cap (m) | 33.10 |
| Dividend yield | - |
| ISIN | FI0009005482 |
| Volume | 14,040 |
| Exchange Venue | HEL |
Company Profile
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products and systems for diagnostic analysis for the use of research institutions, health care and industry.
Key Information
| Price/Earning | - |
| Price/Book | 2.21 |
| Price/Sales | 3.42 |
| P/CF | - |
| Rev Growth (3 year avg) | - |
| EPS Growth (3 year avg) | - |
| Operating Margin % | - |
| Net Margin % | - |
| Return on Equity | - |
| Debt/Equity | - |
Documents
Prospectus
| en 07/09/2018 |
Annual Report
| en 31/12/2019 |
Financials
Income Statement
| EUR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 4 | 6 | 8 | 9 | 10 | - |
| Operating Income (m) | -5 | -4 | -3 | -2 | -2 | - |
| Net Income (m) | -1 | -3 | -3 | 6 | -2 | - |
| Basic EPS | -0.32 | -0.20 | -0.22 | 0.42 | -0.14 | - |
| Avg. Diluted Shares Outstanding (m) | 15 | 15 | 15 | 15 | 15 | - |
Balance Sheet
| EUR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 12 | 9 | 11 | 11 | 12 | - |
| Non Current Assets (m) | 2 | 3 | 2 | 8 | 6 | - |
| Total Assets (m) | 15 | 12 | 13 | 19 | 18 | - |
| Current Liabilities (m) | 2 | 1 | 2 | 1 | 2 | - |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 13 | 10 | 11 | 17 | 16 | - |
Cash Flows
| EUR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | -3 | -3 | -2 | -1 | - | |
| Capital Expenditure (m) | - |
Figures are quoted in EUR unless stated otherwise
€
-
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.